ERG expression in prostate cancer: The prognostic paradox. Issue 15 (29th August 2014)
- Record Type:
- Journal Article
- Title:
- ERG expression in prostate cancer: The prognostic paradox. Issue 15 (29th August 2014)
- Main Title:
- ERG expression in prostate cancer: The prognostic paradox
- Authors:
- Taris, Michael
Irani, Jacques
Blanchet, Pascal
Multigner, Luc
Cathelineau, Xavier
Fromont, Gaelle - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="pros22863-sec-0001" sec-type="section"> <title>BACKGROUND</title> <p> <italic>TMPRSS2/ERG</italic> fusion resulting in ERG overexpression occurs in 30 to 50% of prostate cancer (PCa) in Caucasian patients, but its prognostic relevance remains controversial. In the present study, we investigated ERG expression in all stages of PCa progression, and evaluated the prognostic impact of ERG status in clinically localized PCa (CLC) and in castration resistant disease (CRPC).</p> </sec> <sec id="pros22863-sec-0002" sec-type="section"> <title>METHODS</title> <p>ERG and AR expressions were evaluated by immunohistochemistry on tissue microarrays containing samples of high grade PIN (n = 57), CLC surgically treated (n = 299, including 185 Caucasians and 114 African‐Caribbeans), metastases (n = 17), and CRPC (n = 41).</p> </sec> <sec id="pros22863-sec-0003" sec-type="section"> <title>RESULTS</title> <p>In Caucasians, ERG expression significantly increased from high grade PIN (17.5%) to pT2 (27%) and pT3 CLC (43%), then to metastases (53%). In CLC, stainings for ERG and AR were correlated, and ERG expression was less frequent in African–Caribbeans compared to Caucasians (11.5% vs. 33%). In Caucasians CLC, ERG was associated with longer recurrence free survival, after adjusting for classical prognostic markers. In CRPC, ERG was expressed in 29% of cases, and was associated with a longer overall<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="pros22863-sec-0001" sec-type="section"> <title>BACKGROUND</title> <p> <italic>TMPRSS2/ERG</italic> fusion resulting in ERG overexpression occurs in 30 to 50% of prostate cancer (PCa) in Caucasian patients, but its prognostic relevance remains controversial. In the present study, we investigated ERG expression in all stages of PCa progression, and evaluated the prognostic impact of ERG status in clinically localized PCa (CLC) and in castration resistant disease (CRPC).</p> </sec> <sec id="pros22863-sec-0002" sec-type="section"> <title>METHODS</title> <p>ERG and AR expressions were evaluated by immunohistochemistry on tissue microarrays containing samples of high grade PIN (n = 57), CLC surgically treated (n = 299, including 185 Caucasians and 114 African‐Caribbeans), metastases (n = 17), and CRPC (n = 41).</p> </sec> <sec id="pros22863-sec-0003" sec-type="section"> <title>RESULTS</title> <p>In Caucasians, ERG expression significantly increased from high grade PIN (17.5%) to pT2 (27%) and pT3 CLC (43%), then to metastases (53%). In CLC, stainings for ERG and AR were correlated, and ERG expression was less frequent in African–Caribbeans compared to Caucasians (11.5% vs. 33%). In Caucasians CLC, ERG was associated with longer recurrence free survival, after adjusting for classical prognostic markers. In CRPC, ERG was expressed in 29% of cases, and was associated with a longer overall survival.</p> </sec> <sec id="pros22863-sec-0004" sec-type="section"> <title>CONCLUSIONS</title> <p>Our results confirm that ERG expression is less frequent in PCa from patients of African descent. Although ERG expression increases during PCa natural history, positive ERG status is associated with better outcome in both CLC and CRPC. This paradox could be explained in part by the fact that ERG expression is AR dependant, then ERG positive cancers are likely to progress in a rich androgen environment, with a better response to androgen suppression. <italic>Prostate 74:1481–1487, 2014</italic>. © 2014 Wiley Periodicals, Inc.</p> </sec> </abstract> … (more)
- Is Part Of:
- Prostate. Volume 74:Issue 15(2014)
- Journal:
- Prostate
- Issue:
- Volume 74:Issue 15(2014)
- Issue Display:
- Volume 74, Issue 15 (2014)
- Year:
- 2014
- Volume:
- 74
- Issue:
- 15
- Issue Sort Value:
- 2014-0074-0015-0000
- Page Start:
- 1481
- Page End:
- 1487
- Publication Date:
- 2014-08-29
- Subjects:
- Prostate -- Diseases -- Periodicals
616 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0045 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/pros.22863 ↗
- Languages:
- English
- ISSNs:
- 0270-4137
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6935.194000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 4209.xml